Title : The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells.

Pub. Date : 2020 Aug 15

PMID : 32497533






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therapeutically, co-treatment with LCL161 at low cytotoxic concentrations restored the sensitivity to the known ABCB1 substrate, paclitaxel, in ABCB1-expressing cancer cells and increased the sensitivity to tamoxifen in MCF7-TamC3 cells. Paclitaxel ATP binding cassette subfamily B member 1 Homo sapiens
2 Therapeutically, co-treatment with LCL161 at low cytotoxic concentrations restored the sensitivity to the known ABCB1 substrate, paclitaxel, in ABCB1-expressing cancer cells and increased the sensitivity to tamoxifen in MCF7-TamC3 cells. Paclitaxel ATP binding cassette subfamily B member 1 Homo sapiens